Who is sponsoring NCT03531463?

NCT03531463 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT03531463?

Interventions in NCT03531463: Operative treatment with Reversed Total Shoulder Prosthesis.

What condition does NCT03531463 study?

NCT03531463 studies Proximal Humeral Fracture.

Is NCT03531463 still recruiting?

NCT03531463 is currently active, enrolled. Last updated 6 January 2026.

Last reviewed 2026-01-06 · How we verify

NCT03531463: DeltaCon

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly

Active, enrolled NA Last updated 6 January 2026

What this trial tests

NA trial testing Operative treatment with Reversed Total Shoulder Prosthesis in Proximal Humeral Fracture in 154 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 October 2018

Primary endpoint
10 December 2023

10 December 2028

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	154
Start date	1 October 2018
Primary completion	10 December 2023
Estimated completion	10 December 2028
Sites	3 locations across Denmark, Finland, Norway

Drugs / interventions tested

Operative treatment with Reversed Total Shoulder Prosthesis

Conditions studied

Proximal Humeral Fracture — all drugs for Proximal Humeral Fracture →

Sponsor

Oslo University Hospital

Who can join

Adults 65 to 85, any sex, with Proximal Humeral Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Nordic DeltaCon Trial is a prospective, single-blinded, randomized, controlled, multi-center and multi-national trial comparing reverse prosthesis and non-operative treatment in displaced proximal humerus fractures, in the elderly patients aged 65 to 85 years with displaced OTA/AO group B2 or C2 fractures (According to the new 2018 revision: AO/OTA (Orthopaedic Trauma Association) group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. )

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Surgery with locking plate or hemiarthroplasty versus nonoperative treatment of 3-4-part proximal humerus fractures in older patients (NITEP): An open-label randomized trial.
Launonen AP, Sumrein BO, Reito A, Lepola V, et al · · 2023 · cited 17× · PMID 38015877 · DOI 10.1371/journal.pmed.1004308
Nordic Innovative Trials to Evaluate osteoPorotic Fractures (NITEP) Collaboration: The Nordic DeltaCon Trial protocol-non-operative treatment versus reversed total shoulder arthroplasty in patients 65 years of age and older with a displaced proximal humerus fracture: a prospectiv
Launonen AP, Fjalestad T, Laitinen MK, Lähdeoja T, et al · · 2019 · cited 13× · PMID 30700485 · DOI 10.1136/bmjopen-2018-024916
Assessment of therapeutic clinical trials for proximal humeral fractures.
Koa J, Fares MY, Daher M, Abboud JA. · · 2024 · cited 2× · PMID 38556914 · DOI 10.5397/cise.2023.00521

Verify or expand the search:

Other recruiting trials for Proximal Humeral Fracture

Currently open trials in the same condition.

NCT06416618 — Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years · NA · recruiting
NCT05703958 — Exactech Proximal Humerus Fracture Plate System Post Market Clinical Follow-up · recruiting
NCT06444828 — Comparing Outcomes of Non-surgical Versus Surgical Treatment of Shoulder Fractures With Different Shoulder Replacements · NA · active not recruiting
NCT06133920 — Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures · recruiting
NCT04523415 — Researches About Proximal Humerus Fractures · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03531463 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 21 May 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 6 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03531463.